focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 290.50
Bid: 290.40
Ask: 290.70
Change: 16.70 (6.10%)
Spread: 0.30 (0.103%)
Open: 293.00
High: 300.00
Low: 286.90
Prev. Close: 273.80
MKS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

12 Sep 2016 15:37

RNS Number : 5983J
Marks & Spencer Group PLC
12 September 2016
 

 

 

 

Issued: 12 September 2016

Marks and Spencer Group plc announces

the departure of Laura Wade-Gery

 

M&S today announces that it has agreed with Laura Wade-Gery that, following her maternity leave, Laura will not be returning to her position as Executive Director, Multi-Channel, and will be leaving the company at the end of September. Laura will step down from the Board with immediate effect. There are no further changes to the previously announced responsibilities covering her maternity.

 

Commenting on the announcement, Robert Swannell, Chairman of Marks and Spencer Group plc, said: "On behalf of the Board, I would like to thank Laura very much for the significant contribution she has made in her five years at M&S. Laura has been a valued member of the Board and instrumental in the improvement and modernisation of our ecommerce and multi-channel capabilities. We wish her all the very best for the future."

 

Steve Rowe, Chief Executive, said: "Laura has been a great colleague and has achieved much in her role heading our multi-channel business. I am grateful to Laura for her contribution and she leaves M&S with my personal thanks and best wishes."

 

Laura Wade-Gery said: "I have had five very happy years at M&S. I've been away from the business for a year now, and that time has seen some significant changes in both my personal life and in the business. I concluded that the time was right to move on from M&S. I wish Steve and all my colleagues and friends every success".

 

Remuneration:

The following information is provided in accordance with section 430(2B) of the Companies Act 2006:

· Laura Wade-Gery's remuneration terms will be in line with the key provisions for contract termination as per Marks and Spencer Group plc's Executive Remuneration Policy approved by shareholders in 2014.

· Laura will receive monthly payments of up to a maximum of eight months' salary and benefits, subject to mitigation.

· Any unvested nil-cost options awarded to Laura Wade-Gery under the Deferred Share Bonus Plan will vest in full on termination and may then be exercised in accordance with the Plan rules.

· Any unvested nil-cost options awarded under the Performance Share Plan will be time pro-rated and will vest, subject to performance conditions on a wait and see basis at the normal vesting date and may then be exercised in accordance with the Plan rules.

· Laura Wade-Gery will not be eligible to participate in the Annual Bonus or Performance Share Plan awards for 2016/17.

· Further details of the operation of the Deferred Share Award and Performance Share Plan are set out in the Directors' Remuneration Report in our Annual Report and Financial Statements 2016. Full disclosure of these remuneration arrangements will be provided in our Directors' Remuneration Report in 2017.

 

- Ends -

 

For further information, please contact:

Corporate Press Office: +44 (0)20 8718 1919

Out of hours calls: +44 (0)20 8718 2000

 

Investor Relations:

Fraser Ramzan +44 (0)20 8718 4625

Helen Cox +44 (0)20 8718 8491

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGMLDZVGVZM
Date   Source Headline
28th Jul 202110:53 amRNSDirector/PDMR Shareholding
27th Jul 20214:30 pmRNSDirector/PDMR Shareholding
22nd Jul 202111:30 amRNSDirectorate Change
7th Jul 20212:30 pmRNSNominal Value Reduction
6th Jul 20212:32 pmRNSResult of AGM
1st Jul 20219:00 amRNSBlock listing Interim Review
1st Jul 20219:00 amRNSTotal Voting Rights
30th Jun 202110:00 amRNSDirector/PDMR Shareholding
29th Jun 202110:35 amRNSDirector/PDMR Shareholding
24th Jun 20215:10 pmRNSHolding(s) in Company
21st Jun 20214:15 pmRNSDirector/PDMR Shareholding
2nd Jun 202110:00 amRNSAnnual Financial Report
1st Jun 20214:46 pmRNSHolding(s) in Company
1st Jun 20219:00 amRNSTotal Voting Rights
28th May 202111:04 amRNSDirector/PDMR Shareholding
26th May 20217:00 amRNSFinal Results
24th May 20214:34 pmRNSHolding(s) in Company
24th May 20218:58 amRNSHolding(s) in Company
20th May 20216:17 pmRNSHolding(s) in Company
18th May 202112:00 pmRNSM&S Realigns Management Structure
4th May 20214:53 pmRNSHolding(s) in Company
4th May 20219:00 amRNSTotal Voting Rights
30th Apr 20213:22 pmRNSDirectorate Change
28th Apr 202110:19 amRNSDirector/PDMR Shareholding
22nd Apr 20219:00 amRNSDirectorate Change
13th Apr 20211:30 pmRNSUpdate on Revolving Credit Facility
9th Apr 20215:16 pmRNSDirector/PDMR Shareholding
1st Apr 20219:00 amRNSTotal Voting Rights
31st Mar 202111:00 amRNSDirector/PDMR Shareholding
30th Mar 202111:42 amRNSDirector/PDMR Shareholding
29th Mar 202111:06 amRNSHolding(s) in Company
26th Mar 20212:05 pmRNSHolding(s) in Company
24th Mar 20219:00 amRNSDirectorate Change
16th Mar 20219:15 amRNSDirectorate Change
2nd Mar 202111:04 amRNSDirector/PDMR Shareholding
1st Mar 20219:00 amRNSTotal Voting Rights
9th Feb 20216:18 pmRNSHolding(s) in Company
1st Feb 20219:00 amRNSTotal Voting Rights
28th Jan 202112:25 pmRNSDirector/PDMR Shareholding
27th Jan 20212:29 pmRNSHolding(s) in Company
8th Jan 20217:00 amRNS3rd Quarter Trading Statement
6th Jan 20214:36 pmRNSHolding(s) in Company
4th Jan 20219:00 amRNSBlock listing Interim Review
4th Jan 20219:00 amRNSTotal Voting Rights
31st Dec 202012:43 pmRNSHolding(s) in Company
30th Dec 20201:31 pmRNSHolding(s) in Company
30th Dec 202010:27 amRNSDirector/PDMR Shareholding
21st Dec 20209:00 amRNS2020 PSP Award Targets
18th Dec 20209:04 amRNSDirectorate Change
14th Dec 20209:00 amRNSCreation of ESG Board Committee

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.